StreetAlpha.app
Home › Stocks › KRRO

Korro Bio, Inc. (KRRO)

$12.18
▼ −0.08%
LAST CLOSE · NOV 20

Korro Bio develops RNA editing medicines for rare and common diseases, with its programs still in research or preclinical stages. It last closed at $12.18 on Nov 20, down 0.08% on the day. The next earnings report for KRRO is expected around Mon, Mar 8, 2027. For the quarter ended Sep 2026, KRRO reported EPS of -$0.98 on revenue of $0, with revenue down 100.0% from a year ago. Over its last 8 reports the stock moved an average of 16.2% the session after earnings. Over the last 12 months KRRO insiders bought $21.7M of stock on the open market and sold $6.7M, according to SEC Form 4 filings.

AI Auto Pilots
Is KRRO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold KRRO.

Key Stats

Last 12 months
Results
Revenue
$1.3M
−82.5% vs a year ago
Net income
−$106.1M
−8214.5% margin
EPS (diluted)
−$8.89
Free cash flow
−$63.9M
−4943.8% margin
Valuation
Market cap
$167.2M
13.7M shares
P/E
–
No P/E while losing money
Price to sales
129.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$40.2M
At Sep 30
Shares outstanding
13.7M
At Nov 3
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $14.1M$14.1MFY2021FY2022: $0$0FY2022FY2023: $0$0FY2023FY2024: $2.3M$2.3MFY2024FY2025: $6.4M$6.4MFY2025

From KRRO's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Mar 8
Estimated date · Time not announced
Reported EPS
-$0.98
Quarter ended Sep 2026
Year ago EPS
-$1.92
Same quarter last year
Revenue
$0
−100.0% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$2.26Dec '24Mar 2025: -$2.49Mar '25Jun 2025: -$2.74Jun '25Sep 2025: -$1.92Sep '25Dec 2025: -$5.32Dec '25Mar 2026: -$1.69Mar '26Jun 2026: -$1.07Jun '26Sep 2026: -$0.98Sep '26Latest -$0.98
Revenue by quarter
Dec 2024: $2.3MDec '24Mar 2025: $2.5MMar '25Jun 2025: $1.5MJun '25Sep 2025: $1.1MSep '25Dec 2025: $1.3MDec '25Mar 2026: $0Mar '26Jun 2026: $0Jun '26Sep 2026: $0Sep '26Latest $0
How KRRO moved after its last 8 reports
Average move the session after a report ±16.2%
Nov 5, 2026Time not announced−11.4%
Aug 6, 2026Time not announced+5.4%
May 7, 2026Time not announced−3.4%
Mar 9, 2026Time not announced+10.0%
Nov 12, 2025After the close−79.3%
Aug 12, 2025Time not announced+6.3%
May 7, 2025After the close+10.6%
Mar 18, 2025Time not announced−3.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on KRROStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on KRRO
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on KRRO

Technical Analysis

KRRO · as of the Nov 20 close · updated each morning
Moving sideways

The stock sits between its 20 and 50 day averages. It is sitting right on its 200 day average, a level many traders watch. Momentum is weak (RSI 44). The nearest support is the 200 day average at $12.16, and the nearest resistance the 100 day average at $12.22.

Short trendNeutral
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityHigh, 10.3%/day
Key levels
$17.3552 week high+42.4%
$14.0220 day average+15.1%
$13.07Swing high (Jun 12)+7.3%
$12.75Pivot R1+4.7%
$12.38Pivot+1.6%
$12.22100 day average+0.3%
$12.18Last close
$12.16200 day average−0.2%
$11.97Swing low (Jun 25)−1.7%
$11.81Pivot S1−3.0%
$11.7850 day average−3.3%
$5.2052 week low−57.3%
Indicators
RSI (14)44.25Middle of its rangeNeutral
MACD0.19Below its signal lineBearish
Stochastic13.2Near the bottom of its rangeOversold
ADX (14)22.4Weak trend
Williams %R-88.4Oversold below −80, overbought above −20Oversold
CCI (20)-100.8Oversold below −100, overbought above 100Oversold
Rate of change−17.4%Change over 10 sessionsBearish
ATR (14)$1.26Typical daily range, 10.3% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Below
MA 200Above
What happened before, for KRRO

What happened before

See how KRRO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow KRRO usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How KRRO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for KRROHow many large options trades hit KRRO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

KRRO Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ●54 buying vs 47 selling
  • ▼Held by funds -7.7 pts
  • ▼Funds holding -3
  • ▼Superinvestors: 0 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding105108−2.8%
In funds' top 10440.0%
Held by funds102.2%109.9%−7.7 pts
New / increased14 / 4019 / 48−19.4%
Reduced / sold out30 / 1719 / 11+56.7%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See KRRO institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

KRRO Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$21.7M12 buys · 10 insiders
Sold$6.7M16 sales · 6 insiders
93% of the selling was under pre-arranged trading plans.
Cluster buy: 10 insiders bought $20.7M between Mar 10 and Mar 31.
2026-03 bought $20.7M2026-05 sold $237K2026-06 sold $2.6M2026-07 sold $1.5M2026-08 bought $79K2026-08 sold $496K2026-09 sold $786K2026-10 bought $885K2026-11 sold $974KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 12Jean Francois FormelaDirectorSale plan66,632$14.61$974K
Oct 26Lynx1 Capital Management LP10% ownerBuy79,809$11.09$885K
Sep 14Jean Francois FormelaDirectorSale plan48,690$14.09$686K
Sep 11Oliver DolanSenior Vice President, FinanceSale plan5$13.72$69
Sep 9Oliver DolanSenior Vice President, FinanceSale plan7,353$13.51$99K
Aug 26Jean Francois FormelaDirectorSale plan300$13.96$4K
Every insider buy and sale for KRRO over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See KRRO insider trades →

From SEC Form 4 filings by KRRO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether KRRO is in one of them and how their past KRRO trades turned out.

KRRO in the AI portfolios
Loading…

KRRO News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered KRRO in an article yet. Here's the latest on the wider market.

KRRO in the news

About Korro Bio

Korro Bio is a biopharmaceutical company based in Cambridge, Massachusetts, that is developing a new class of genetic medicines that edit RNA rather than DNA. Its approach uses engineered oligonucleotides that work with a natural cell process to make precise, temporary changes to proteins. The company aims to treat both rare and widely prevalent diseases, including urea cycle disorders, liver conditions and ALS, but its programs are still in research or preclinical development.

Headquarters
Cambridge, MA